Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Cardiovascular Systems Inc. (“Cardiovascular Systems” or the “Company”) (NASDAQ: CSII). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased shares of Cardiovascular Systems during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the complaint, on May 8, 2014, the Company received a letter from the U.S. Attorney’s Office for the Western District of North Carolina stating that Cardiovascular Systems is being investigated for possible violations of the False Claims Act. On July 8, 2015, Cardiovascular Systems further revealed that a whistleblower lawsuit filed in 2013 had been unsealed alleging that Cardiovascular Systems engaged in a fraudulent marketing scheme to maximize profits through illegal kickbacks.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Khang & Khang LLPJoon M. Khang, Esq.Telephone: 949-419-3834Facsimile: 949-225-4474joon@khanglaw.com

Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more Cardiovascular Systems Charts.
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more Cardiovascular Systems Charts.